Assessment, goal setting, and botulinum neurotoxin a therapy in the management of post-stroke spastic movement disorder: updated perspectives on best practice-Reference-Cited by-同舟云学术

Assessment, goal setting, and botulinum neurotoxin a therapy in the management of post-stroke spastic movement disorder: updated perspectives on best practice

Published:2021-12-30 Issue:1 Volume:22 Page:27-42
ISSN:1473-7175
Container-title:Expert Review of Neurotherapeutics
language:en
Short-container-title:Expert Review of Neurotherapeutics

Author:

Wissel Jörg¹²^ORCID,Ri Songjin²³

Affiliation:

1. Department of Neurorehabilitation and Physical Therapy, Vivantes Klinikum Spandau, Neue Bergstrasse 6, 13585 Berlin, Germany

2. Neurology and Psychosomatics at Wittenbergplatz, Out-Patient-Clinic, Ansbacher straße 17-19, 10787 Berlin, Germany

3. Department of Neurology, Charité University Hospital (CBS), Hindenburgdamm 30, Berlin 12203, Germany

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Neurology (clinical),General Neuroscience

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737175.2021.2021072

Reference170 articles.

1. Toward an epidemiology of poststroke spasticity

2. Platz T, Wissel J, Donauer E, et al. [S2k-guideline: treatment of spastic syndrome. DGNeurology]. German 2019. [cited 2021 Nov 06]. Available from: https://doi.org/10.1007/s42451-019-0090-2** recent update of the management of spastic movement disorder

3. Early development of spasticity following stroke: a prospective, observational trial

4. Occurence and Clinical Predictors of Spasticity After Ischemic Stroke

5. Post-stroke Spasticity: Predictors of Early Development and Considerations for Therapeutic Intervention

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effectiveness of early interventions for post-stroke spasticity: a systematic review;Disability and Rehabilitation;2024-06-22

2. The Role of Botulinum Toxin Type-A in Spasticity: Research Trends from a Bibliometric Analysis;Toxins;2024-04-09

3. Real-world differences in dosing and clinical utilization of OnabotulinumtoxinA and AbobotulinumtoxinA in the treatment of upper limb spasticity;Toxicon;2024-04

4. Hyperbaric oxygen therapy for thalamic pain syndrome: case report;Frontiers in Neurology;2024-03-13

5. Acupuncture for post-stroke spasticity: An overview of systematic reviews;Complementary Therapies in Medicine;2024-03